Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: Fungal mural endocarditis is a rare entity in which the antemortem diagnosis is seldom made. Seven cases of mural endocarditis caused by Candida spp. have been collected from literature and six of these patients died after treatment with amphotericin B. Case presentation: We report a case of mural endocarditis diagnosed by transesophageal echocardiogram and positive blood cultures to Candida parapsilosis. Because blood cultures continued to yield C. parapsilosis despite caspofungin monotherapy, treatment with voriconazole was added. Conclusion: This is the first description of successful treatment of C. parapsilosis mural endocarditis with caspofungin and voriconazole.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weems, J. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.3.756 · Cited by 399 · cited 1×
“parapsilosis as a nosocomial pathogen associated with invasive devices and parenteral nutrition has been emphasized [14].”
BackgroundIn Vitro Activity of Caspofungin against Candida albicans Biofilms
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3591-3596.2002 · Cited by 288
Penetration of Candida Biofilms by Antifungal Agents
Al-Fattani, M. A., & Douglas, L. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3291-3297.2004 · Cited by 235 · cited 1×
“Caspofungin inhibits beta-1,3-D-glucan synthesis in the cell wall, a target present in fungal cells, and has shown excellent activity against Candida biofilm [21] as opposed to poor penetration of voriconazole [22,23].”
Background
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
“LFAmB, fluconazole, or voriconazole [209, 221, 222].”
Candida parapsilosis, an Emerging Fungal Pathogen
Trofa, D., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 854
The Role of Fluconazole in the Treatment of Candida Endocarditis: A Meta-Analysis
Smego, R. A., & Ahmad, H. (2011) · Medicine · doi:10.1097/md.0b013e3182259d38 · Cited by 56
“Voriconazole, but not posaconazole, has been used in the treatment of Candida endocarditis, but clinical experience is extremely limited.(48,52,53,67) While fluconazole is commonly used for chronic suppression in patients with Candida endocarditis, to our knowledge its precise role in the management of this infection…”
Metadata
- Authors
- López-Ciudad, V., Castro-Orjales, M. J., León, C., Sanz-Rodríguez, C., de la Torre-Fernández, M. J., de Juan-Romero, M. A. P., Collell-Llach, M. D., & Díaz-López, M. D.
- Venue
- BMC Infectious Diseases
- Published
- 2006-04-11
- Volume
- 6
- Issue
- 1
- Pages
- 73-73
- ISSN
- 1471-2334 (ISSN-L)
- OpenAlex
- W2159394449
- Cited by
- 52
- References
- 4
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. https://app.cochat.ai/papers/10.1186/1471-2334-6-73
- The paper
- López-Ciudad, V., Castro-Orjales, M. J., León, C., Sanz-Rodríguez, C., de la Torre-Fernández, M. J., de Juan-Romero, M. A. P., Collell-Llach, M. D., & Díaz-López, M. D. (2006). Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC Infectious Diseases. https://doi.org/10.1186/1471-2334-6-73
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.